CXCL12 and breast cancer: In patients with luminal A breast cancer, high expressions of BMP-4, SDF-1, and vimentin demonstrated a more substantial positive impact on overall survival (Figure 7B; BMP-4 p = 0.0025; SDF-1 p = 0.0019; vimentin p = 0.00051).